SCHEMBL6710125

SCHEMBL6710125

O=C(Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 4/20 0.48
KDM4E B2RXH2 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PRSS12 P56730 2/20 0.41
NHERF1 O14745 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
STK33 Q9BYT3 1/20 0.40
SUCNR1 Q9BXA5 2/20 0.40
PLCG2 P16885 1/20 0.39
F10 P00742 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713754 0.95 SERPINE1 (0.43) SERPINE1KDM4ENPSR1RXFP1NHERF1
SCHEMBL6713211 0.91 PARP14 (0.42) SERPINE1KDM4ENPSR1RXFP1MEN1
SCHEMBL6710319 0.91 CHRNB2 (0.43) SERPINE1MAPTNHERF1PLCG2F10
SCHEMBL6708019 0.90 GPR35 (0.44) MAPTNHERF1STK33PLCG2
SCHEMBL6711906 0.89 NHERF1 (0.46) NPC1RAB9ALMNASMN1; SMN2NHERF1
SCHEMBL6713933 0.89 RXFP1 (0.41) KDM4ERXFP1MEN1KMT2ANPC1
SCHEMBL6708001 0.88 MEN1 (0.45) RXFP1MEN1KMT2ANPC1MAPT
SCHEMBL6710112 0.88 MAP3K5 (0.45) KDM4ERXFP1NPC1MAPTRAB9A
SCHEMBL6708855 0.88 KDR (0.45) KDM4ENPSR1MEN1KMT2AMAPT
SCHEMBL6707952 0.87 PRSS12 (0.39) SERPINE1RXFP1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 SERPINE1 2108/4885KDM4E 1582/4885NPSR1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.